GLIBESYN

This brand name is authorized in Cyprus

Active ingredients

The drug GLIBESYN contains one active pharmaceutical ingredient (API):

1 Glibenclamide
UNII SX6K58TVWC - GLYBURIDE

Glibenclamide, a second-generation, short half-life sulphonylurea, is a hypoglycaemic agent that reduces blood-glucose by stimulating insulin release by the pancreas. Sulphonylureas act on pancreatic beta-cells by inhibiting ATP-sensitive potassium channels.

Read about Glibenclamide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
GLIBESYN Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A10BB01 Glibenclamide A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB01

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.